JPS5738786A - Cephalosporin sulfoxide derivative, manufacture and drug composition containing it - Google Patents

Cephalosporin sulfoxide derivative, manufacture and drug composition containing it

Info

Publication number
JPS5738786A
JPS5738786A JP10076581A JP10076581A JPS5738786A JP S5738786 A JPS5738786 A JP S5738786A JP 10076581 A JP10076581 A JP 10076581A JP 10076581 A JP10076581 A JP 10076581A JP S5738786 A JPS5738786 A JP S5738786A
Authority
JP
Japan
Prior art keywords
manufacture
composition containing
drug composition
sulfoxide derivative
cephalosporin sulfoxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10076581A
Other languages
English (en)
Japanese (ja)
Inventor
Rabiyuu Berunaaru
Saari Ari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of JPS5738786A publication Critical patent/JPS5738786A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
    • A61K47/552—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds one of the codrug's components being an antibiotic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP10076581A 1980-06-30 1981-06-30 Cephalosporin sulfoxide derivative, manufacture and drug composition containing it Pending JPS5738786A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8014512A FR2485540A1 (fr) 1980-06-30 1980-06-30 Nouveaux derives antibiotiques des cephalosporines, leur procede de preparation et les medicaments en contenant

Publications (1)

Publication Number Publication Date
JPS5738786A true JPS5738786A (en) 1982-03-03

Family

ID=9243670

Family Applications (2)

Application Number Title Priority Date Filing Date
JP10076581A Pending JPS5738786A (en) 1980-06-30 1981-06-30 Cephalosporin sulfoxide derivative, manufacture and drug composition containing it
JP10076481A Pending JPS5738785A (en) 1980-06-30 1981-06-30 3-(hydroxy-1,2,4-triazinyl)thiomethylcephalosporin , manufacture and drug composition containing same

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP10076481A Pending JPS5738785A (en) 1980-06-30 1981-06-30 3-(hydroxy-1,2,4-triazinyl)thiomethylcephalosporin , manufacture and drug composition containing same

Country Status (4)

Country Link
JP (2) JPS5738786A (show.php)
AU (1) AU7241081A (show.php)
FR (1) FR2485540A1 (show.php)
ZA (2) ZA814394B (show.php)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5798288A (en) * 1980-10-29 1982-06-18 Fujisawa Pharmaceut Co Ltd Novel cephem compound or its salt, their preparation, and preventive and remedy for bacteriosis containing said compound as active component
JPS58162592A (ja) * 1982-03-04 1983-09-27 ヘキスト　アクチェンゲゼルシャフト セフアロスポリン誘導体およびその製造方法
JP2007503447A (ja) * 2003-08-25 2007-02-22 リヴァアックス ファーマスーティカルズ，エルエルシー 神経治療セファゾリン経口投与組成物

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2546520B1 (fr) * 1983-05-27 1985-08-30 Sanofi Sa Nouveaux composes antibiotiques derives des cephalosporines

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5798288A (en) * 1980-10-29 1982-06-18 Fujisawa Pharmaceut Co Ltd Novel cephem compound or its salt, their preparation, and preventive and remedy for bacteriosis containing said compound as active component
JPS58162592A (ja) * 1982-03-04 1983-09-27 ヘキスト　アクチェンゲゼルシャフト セフアロスポリン誘導体およびその製造方法
JP2007503447A (ja) * 2003-08-25 2007-02-22 リヴァアックス ファーマスーティカルズ，エルエルシー 神経治療セファゾリン経口投与組成物

Also Published As

Publication number Publication date
ZA814394B (en) 1982-09-29
FR2485540A1 (fr) 1981-12-31
FR2485540B1 (show.php) 1984-02-24
AU7241081A (en) 1982-01-07
ZA814392B (en) 1982-07-28
JPS5738785A (en) 1982-03-03

Similar Documents

Publication Publication Date Title
PH17194A (en) Novel carbostyril derivatives,and pharmaceutical composition containing the same
JPS5764669A (en) Novel indole derivative, manufacture and medicinal composition containing same
JPS6452763A (en) Novel heterocyclic derivative, manufacture and medicinal composition
JPS5775976A (en) Novel heterocyclic derivative, manufacture and medicinal composition containing same
JPS57167991A (en) Cephalosporin derivative, manufacture and antibacterial medicine containing same
JPS5758682A (en) Thiazoline derivatives, manufacture and medicinal composition containing same
JPS5777679A (en) Novel heterocyclic derivative, manufacture and pharmaceutical composition containing same
IL63145A (en) Imidazothienopyrimidinedione derivatives,their manufacture and pharmaceutical compositions containing them
IL62167A0 (en) Phenoxy-aminopropanol derivatives,their manufacture and pharmaceutical compositions containing them
JPS5731686A (en) Xanthine derivatives, manufacture and medicinal composition containing them
JPS5738786A (en) Cephalosporin sulfoxide derivative, manufacture and drug composition containing it
IL62431A0 (en) Cephalosporin derivatives,their manufacture and pharmaceutical compositions containing them
JPS5775975A (en) Heterocyclic derivative, manufacture and medicinal composition containing same
IL66814A0 (en) Cephalosporin derivatives,their manufacture and pharmaceutical compositions containing them
IL62592A (en) Octahydrophenyl-quinolizine derivatives,their manufacture and pharmaceutical compositions containing them
PH16754A (en) Novel acylamino-benzazole derivatives,and pharmaceutical composition containing same
JPS56139482A (en) 3-chloro-quinoline derivative, manufacture and medicinal composition
JPS5738784A (en) Penicillin derivative, manufacture and medicinal composition containing it
JPS56128785A (en) Rifamycin derivative, its manufacture and antibacterial medicinal composition containing it
JPS56156279A (en) Ergoline derivative, its manufacture and medicinal composition containing it
JPS56108780A (en) Prostanid compound*its manufacture and drug composition
ZA821723B (en) Cephalosporin derivatives, pharmaceutical compositions containing the same, and production thereof
JPS5742692A (en) Rifamycin derivative, manufacture and composition
JPS56142300A (en) Steroid-spiro-oxathiazolidine derivatives, manufacture and medicinal composition containing them
JPS57167989A (en) Penicillin derivative, manufacture and antibacterial medicinal composition containing same